2015 Joint Annual Meeting
Search Meeting Site Only
NEAUA Main Site
Annual Meeting Home
Program
Accreditation
Past & Future Meetings

Back to 2015 Joint Annual Meeting


Post PCNL SIRS is not a Predictor of Unplanned Readmission
Rachel A. Moses1, Vidit Sharma2, Eric P. Raffin1, Boyed Viers2, Deepak Agarwal2, Amy Krambeck2, Vernon M. Pais1
1Dartmouth Hitchcock Medical Center Section of Urology, Lebanon, NH;2Mayo Medical Center, Rochester, MN

Introduction: Postoperative Systemic Inflammatory Response Syndrome (SIRS) may be considered an ominous sign. Anecdotally, SIRS is often observed in the otherwise well patient following percutaneous nephrolithotomy (PCNL). We sought to evaluate if SIRS following PCNL is predictive of unplanned 90 day readmission.
Materials & Methods: We retrospectively reviewed consecutive patients undergoing PCNL in two dedicated endourologic practices. Patient characteristics collected included demographics and surgical characteristics. SIRS was defined as having two or more of the following: max white blood cell count >12,000, temperature>38 degrees Celsius, heart rate >90, and respiratory rate >20 within the first 24hrs following PCNL. Chi square analysis was used to compare readmission rates between SIRS and non-SIRS groups.
Results: We identified 382 patients undergoing PCNL, 42% (162/382) that met criteria for SIRS within 24hrs of PCNL. Overall, readmission within 90 days was required in 7.1 % (27/382). Reasons for readmission included urosepsis (6/382), UTI (4/382), pneumonia (4/382), AKI (3/382), blood transfusion (1/382), and other non-related medical issues (9/382). Perioperative SIRS was not associated with readmission, with 3.7% of the SIRS patients requiring readmission for UTI or urosepsis compared with 1.8% without SIRS, (p=0.335).
Conclusions: Nearly half of patients undergoing PCNL met criteria for SIRS. Although an ominous prognosticator in other settings, there was no significant correlation between SIRS and 90 day readmission in the postoperative PCNL patient. This may indicate that patient developing SIRS immediately following PCNL may be otherwise safely discharged without increased likelihood of readmission.


Back to 2015 Joint Annual Meeting